These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Integrative analysis of genomic aberrations associated with prostate cancer progression. Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737 [TBL] [Abstract][Full Text] [Related]
4. Searching for suppressor genes in prostate cancer. Peehl DM Cancer Surv; 1991; 11():25-34. PubMed ID: 1668728 [TBL] [Abstract][Full Text] [Related]
5. Gene expression alterations in human prostate cancer. Luo JH Drugs Today (Barc); 2002 Oct; 38(10):713-9. PubMed ID: 12582456 [TBL] [Abstract][Full Text] [Related]
6. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors. Glinsky GV Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790 [TBL] [Abstract][Full Text] [Related]
7. Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer. Bermudo R; Abia D; Benitez D; Carrió A; Vilella R; Ortiz AR; Thomson TM; Fernández PL Ann N Y Acad Sci; 2010 Oct; 1210():17-24. PubMed ID: 20973795 [TBL] [Abstract][Full Text] [Related]
8. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. Bermudo R; Abia D; Ferrer B; Nayach I; Benguria A; Zaballos A; del Rey J; Miró R; Campo E; Martínez-A C; Ortiz AR; Fernández PL; Thomson TM BMC Cancer; 2008 Oct; 8():315. PubMed ID: 18973659 [TBL] [Abstract][Full Text] [Related]
9. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray. Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025 [TBL] [Abstract][Full Text] [Related]
10. The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression. Lo UG; Lee CF; Lee MS; Hsieh JT Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28973968 [TBL] [Abstract][Full Text] [Related]
11. Network-based approach reveals Y chromosome influences prostate cancer susceptibility. Khosravi P; Gazestani VH; Asgari Y; Law B; Sadeghi M; Goliaei B Comput Biol Med; 2014 Nov; 54():24-31. PubMed ID: 25199846 [TBL] [Abstract][Full Text] [Related]
12. Global methylation analysis identifies PITX2 as an upstream regulator of the androgen receptor and IGF-I receptor genes in prostate cancer. Schayek H; Bentov I; Jacob-Hirsch J; Yeung C; Khanna C; Helman LJ; Plymate SR; Werner H Horm Metab Res; 2012 Jun; 44(7):511-9. PubMed ID: 22495974 [TBL] [Abstract][Full Text] [Related]
17. A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression. Agell L; Hernández S; Nonell L; Lorenzo M; Puigdecanet E; de Muga S; Juanpere N; Bermudo R; Fernández PL; Lorente JA; Serrano S; Lloreta J Am J Pathol; 2012 Nov; 181(5):1585-94. PubMed ID: 23083832 [TBL] [Abstract][Full Text] [Related]
18. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer. Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610 [TBL] [Abstract][Full Text] [Related]
19. Molecular biology of progression of prostate cancer. Nupponen N; Visakorpi T Eur Urol; 1999; 35(5-6):351-4. PubMed ID: 10325488 [TBL] [Abstract][Full Text] [Related]
20. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer. Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]